These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 36542817

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pralsetinib treatment for multiple RET fusions in lung adenocarcinoma: a case report.
    Cao X, Liu X, Wang S, Liu Z, Ren X, Sun D, Deng L.
    J Int Med Res; 2022 Jun; 50(6):3000605221105368. PubMed ID: 35751411
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. FDA Approves Pralsetinib for Treatment of Adults With Metastatic RET Fusion-Positive NSCLC.
    Wright KM.
    Oncology (Williston Park); 2020 Oct 09; 34(10):406-406;431. PubMed ID: 33058106
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Extrapulmonary tuberculosis in patients with RET fusion-positive non-small cell lung cancer treated with pralsetinib: A Korean single-centre compassionate use experience.
    Lee YP, Jeong BH, Eun Y, Kang CI, Park S, Jung HA, Lee SH, Ahn JS, Ahn MJ, Park K, Sun JM.
    Eur J Cancer; 2021 Dec 09; 159():167-173. PubMed ID: 34753013
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. RET-Rearranged Lung Adenocarcinoma with Paraneoplastic Meige Syndrome.
    Abbar B, Henry C, Theou-Anton N, Brosseau S, Nguenang M, Pluvy J, Assoun S, Zalcman G, Gounant V.
    J Thorac Oncol; 2019 Nov 09; 14(11):e250-e251. PubMed ID: 31668323
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of a Novel KIF5B-RET, ABHD17C-RET Double-Fusion Variant in Lung Adenocarcinoma and Response to Cabozantinib.
    Zheng Q, Fang W, Huang Y, Gan J, Zhang L.
    J Thorac Oncol; 2020 Aug 09; 15(8):e132-e133. PubMed ID: 32718536
    [No Abstract] [Full Text] [Related]

  • 14. Pralsetinib: Treatment of metastatic RET fusion-positive non-small cell lung cancer.
    Nguyen L, Monestime S.
    Am J Health Syst Pharm; 2022 Mar 21; 79(7):527-533. PubMed ID: 34864862
    [Abstract] [Full Text] [Related]

  • 15. Pralsetinib: First Approval.
    Markham A.
    Drugs; 2020 Nov 21; 80(17):1865-1870. PubMed ID: 33136236
    [Abstract] [Full Text] [Related]

  • 16. A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma.
    Hida T, Velcheti V, Reckamp KL, Nokihara H, Sachdev P, Kubota T, Nakada T, Dutcus CE, Ren M, Tamura T.
    Lung Cancer; 2019 Dec 21; 138():124-130. PubMed ID: 31710864
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer.
    Lin JJ, Liu SV, McCoach CE, Zhu VW, Tan AC, Yoda S, Peterson J, Do A, Prutisto-Chang K, Dagogo-Jack I, Sequist LV, Wirth LJ, Lennerz JK, Hata AN, Mino-Kenudson M, Nardi V, Ou SI, Tan DS, Gainor JF.
    Ann Oncol; 2020 Dec 21; 31(12):1725-1733. PubMed ID: 33007380
    [Abstract] [Full Text] [Related]

  • 18. RET fusions in non-small-cell lung cancer: an emerging target reshaping the treatment paradigm.
    Saleh K, Khalife N, Felefly T.
    Future Oncol; 2021 Apr 21; 17(12):1445-1448. PubMed ID: 33573417
    [No Abstract] [Full Text] [Related]

  • 19. The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma.
    Zhu YC, Wang WX, Zhang QX, Xu CW, Zhuang W, Du KQ, Chen G, Lv TF, Song Y.
    Clin Lung Cancer; 2019 Jan 21; 20(1):e73-e76. PubMed ID: 30366769
    [No Abstract] [Full Text] [Related]

  • 20. Advances in the treatment of RET-fusion-positive lung cancer.
    Pall G, Gautschi O.
    Lung Cancer; 2021 Jun 21; 156():136-139. PubMed ID: 33933276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.